Quantitative analysis of two dinor urinary metabolites of prostaglandin I2.
D015121:6-Ketoprostaglandin F1 alpha / Q000031:analogs & derivatives* / Q000652:urine; D003903:Deuterium; D011464:Epoprostenol / Q000378:metabolism*; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D006801:Humans; D011453:Prostaglandins / Q000378:metabolism*; D011461:Prostaglandins F, Synthetic / Q000652:urine*; D011865:Radioisotope Dilution Technique; D014316:Tritium
D011453:Prostaglandins; D011461:Prostaglandins F, Synthetic; D014316:Tritium; D015121:6-Ketoprostaglandin F1 alpha; C028290:2,3-dinor-6-ketoprostaglandin F1alpha; C028291:2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin F1alpha; D003903:Deuterium; D011464:Epoprostenol